US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Arginine Depletors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Arginine Depletors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Arginine Depletors- ...  |  read more...
USD 1,250
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Insights, 2015, provides the in-depth analysis of the pipeline assets across the ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitors. The main objective of this report to track competitor ...  |  read more...
USD 1,250
ATPase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The ATPase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, ATPase Inhibitors- ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Aurora A Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Aurora C Kinase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Aurora C Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Bacterial Efflux Pump Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bacterial Efflux Pump Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Bcr-Abl Tyrosine Kinase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bcr-Abl Tyrosine Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Benzodiazepine Receptor Agonist -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Benzodiazepine Receptor Agonist Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Beta Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Beta Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Beta Secretase inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Beta Secretase inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Beta-3 Receptors Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Beta-3 Receptors Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Beta-Lactamase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Beta-Lactamase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Beta-Lactamase Inhibitors- ...  |  read more...
USD 1,250
Bone Morphogenetic Protein (BMP) Receptor Activators -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Receptor Activators. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bone Morphogenetic Protein (BMP) Receptor Activators Report helps to identify emerging players ...  |  read more...
USD 1,250
Brutons Tyrosine Kinase (Btk) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brutons Tyrosine Kinase (Btk) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (CRLR) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists Report helps to identify emerging players ...  |  read more...
USD 1,250
Calcium Sensing Receptor (CaR or CaSR) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Receptor (CaR or CaSR) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Calcium Sensing Receptor (CaR or CaSR) Antagonists Report helps ...  |  read more...
USD 1,250
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (CB2) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cannabinoid Receptor Type 2 (CB2) Agonists Report helps to identify emerging players ...  |  read more...
USD 1,250
Catechol-O-methyltransferase (COMT) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Catechol-O-methyltransferase (COMT) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Cathepsin S inhibitor -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cathepsin S inhibitor Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
CCR2 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The CCR2 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, CCR2 Inhibitors- ...  |  read more...
USD 1,250
CCR3 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The CCR3 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, CCR3 Inhibitors- ...  |  read more...
USD 1,250
CCR5 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The CCR5 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, CCR5 Inhibitors- ...  |  read more...
USD 1,250
CCR9 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The CCR9 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, CCR9 Inhibitors- ...  |  read more...
USD 1,250
CD 40 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The CD 40 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
CD40 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The CD40 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, CD40 Agonists- ...  |  read more...
USD 1,250
1  2  3  4    6    8  9  10